SCHEMBL6278014

SCHEMBL6278014

OCc1ccc(O[SiH3])cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.54
PPARG P37231 2/20 0.44
PPARA Q07869 2/20 0.44
TSHR P16473 1/20 0.43
PRSS1 P07477 1/20 0.39
PRSS2 P07478 1/20 0.39
PRSS3 P35030 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
VHL P40337 1/20 0.38
ELOC Q15369 1/20 0.38
ELOB Q15370 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38
CA5A P35218 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5342317 0.78 LTA4H (0.81) LTA4HPPARGPPARATSHRPRSS1
SCHEMBL41775 0.76 TSHR (0.67) LTA4HPPARGPPARATSHRPRSS1
SCHEMBL3822059 0.76 CA12 (0.38) TSHRCA12CA1CA2CA7
SCHEMBL15417600 0.76 LTA4H (0.62) LTA4HPPARGPPARATSHRPRSS1
SCHEMBL27329 0.74 IDO1 (0.58) LTA4HTSHRCA12CA1CA2
SCHEMBL4181089 0.74 IDO1 (0.58) LTA4HTSHRCA12CA1CA2
SCHEMBL16902869 0.74 LTA4H (0.54) LTA4HPPARGPPARATSHRPRSS1
SCHEMBL120991 0.74 LTA4H (0.54) LTA4HPPARGPPARATSHRPRSS1
SCHEMBL11649743 0.74 HRH3 (0.56) LTA4HPPARGPPARATSHRPRSS1
SCHEMBL728466 0.74 LTA4H (0.54) LTA4HPPARGPPARATSHRPRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005113573-A2 METHOD OF SUPPORT-BASED CHEMICAL SYNTHESIS MIXTURE SCIENCES, INC. (US) 2005-12-01 WO disclosed
US-20050261474-A1 Method of support-based chemical synthesis MIXTURE SCIENCES, INC. 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261474-A1 Method of support-based chemical synthesis CYP2F1, CYP4F3, CYP4F2 LTA4H 2585/4885PPARG 4291/4885PPARA 4323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.